Colorado lawmakers are considering a legislative effort to exempt orphan drugs from pricing limits, a move that could shield medications for rare diseases from the oversight … Read more
Wall Street responded with immediate enthusiasm this week as health insurer stocks jump on higher Medicare Advantage rates finalized by the federal government. The announcement, which … Read more
The White House has submitted a fiscal year 2027 budget request that would fundamentally reshape the landscape of American biomedical research, as a new Trump budget … Read more
Washington D.C. – As former President Donald Trump eyes a potential return to the White House, a key challenge looms: funding his ambitious policy agenda. A … Read more
The way we define obesity is undergoing a critical re-evaluation, and it’s a debate that extends far beyond the familiar metric of the Body Mass Index … Read more
WASHINGTON — Food and Drug Administration Commissioner Robert Califf, a physician himself, addressed agency staff Wednesday, striking a tone of gratitude and acknowledging a difficult first … Read more
WASHINGTON — The Trump administration is preparing an executive order that would impose a 100% tariff on all prescription drugs and their key ingredients imported from … Read more
Washington D.C. Is witnessing a flurry of activity surrounding health savings accounts (HSAs) and Medicare Advantage Health Plans (MAHAs), with industry lobbying efforts intensifying even as … Read more
The federal office responsible for coordinating health information technology is undergoing a structural shift, returning to a focus on external collaboration and streamlining its priorities. The … Read more
The groundbreaking gene editing treatment that saved Baby KJ Muldoon from a previously fatal genetic disease is facing a significant hurdle as researchers attempt to expand … Read more
Cambridge, MA – Takeda Pharmaceutical Company Limited will reduce its workforce in Cambridge, Massachusetts, by nearly 250 positions, the company announced Friday through a required state … Read more
The global pharmaceutical landscape is undergoing a significant shift, and China is rapidly emerging as a central player. For decades, the United States and Europe have … Read more